Artemis Medicare Services Ltd
Healthcare | Small Cap
Artemis Medicare Services demonstrates a mixed financial performance. The company shows strong growth and profitability, but its liquidity and efficiency need improvement. While the company has been successful in expanding its assets and revenues, it faces challenges in managing its short-term obligations and utilizing its fixed assets effectively. Artemis Medicare Services maintains a solid financial position with a good balance between debt and equity. The company's ability to cover its interest expenses and equity dividends is also a positive sign. The company is strong in revenue, operating profit, EPS, asset, and net income growth in the healthcare sector. The company's profitability is strong, and it generates substantial returns on its capital, equity, and assets.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsOvervalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio4.80
- Profitability Ratio10.00
- Efficiency Ratio6.67
- Coverage Ratio8.80
- Solvency Ratio9.00
- Liquidity Ratio6.98
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekBullish
- 1 MonthBullish
Artemis Medicare Services demonstrates a mixed financial performance. The company shows strong growth and profitability, but its liquidity and efficiency need improvement. While the company has been successful in expanding its assets and revenues, it faces challenges in managing its short-term obligations and utilizing its fixed assets effectively. Artemis Medicare Services maintains a solid financial position with a good balance between debt and equity. The company's ability to cover its interest expenses and equity dividends is also a positive sign. The company is strong in revenue, operating profit, EPS, asset, and net income growth in the healthcare sector. The company's profitability is strong, and it generates substantial returns on its capital, equity, and assets.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
39.61
Industry Median
47.76
Small Cap Median
45.36
P/E RATIO
39.49
P/B RATIO
4.38
Industry Median
4.54
Small Cap Median
3.95
P/S RATIO
4.17
Industry Median
3.59
Small Cap Median
2.22
Others
PEG RATIO
0.51
EV/EBITDA RATIO
21.03
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹258.65 as on Jun 21, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Quarterly Report⬤2nd Feb 26
Quarterly Financial Results Q3 FY 2025-26
BULLISH SENTIMENT
Artemis Medicare Services has shown excellent growth across various metrics. The company has experienced significant growth in its revenue, operating profit, earnings per share, assets, and net income. This indicates that the company is expanding its business and improving its profitability. The company's growth ratios suggest that it is well-positioned for future success. The company is experiencing considerable expansion and increased earnings.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 36.03 | 32.79 | 19.27 | 6.6 | 15.37 |
| Operating Profit Growth Rate | 94.29 | 38.24 | 41.49 | 14.29 | 23.68 |
| Earnings Per Share (EPS) Growth | 389.8 | 20 | 25.69 | 65.75 | 9.17 |
| Asset Growth Rate | 18.33 | 27.46 | 7.4 | 39.61 | 5.31 |
| Net Income Growth Rate | 416.67 | 22.58 | 28.95 | 67.35 | 26.83 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Artemis Medicare Services shows mixed performance in its financial metrics. The company's adjusted earnings per share, cash earnings per share and book value per share are weak. However, its capital expenditures are well-managed. The company needs to focus on improving its earnings and book value to enhance its overall financial performance. The company's financial ratios suggest that there is room for improvement in its earnings and asset management.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 2.38 | 2.77 | 3.5 | 5.86 | 6.62 |
| Cash Earnings Per Share (Cash EPS) | 4.08 | 5.31 | 6.36 | 9.07 | 9.5 |
| Book Value Per Share | 27.62 | 31 | 32.07 | 59.86 | 58.44 |
| Dividend Per Share (DPS) | 0 | 0.46 | 0.43 | 0.42 | 0.46 |
| Capital Expenditures (CapEx) | 109 | 144 | 73 | 90 | 100 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
Artemis Medicare Services demonstrates excellent profitability across various metrics. The company has high gross profit margins, return on capital employed, return on equity, return on assets, operating margins, and net margins. This indicates that the company is generating substantial profits from its operations and is effectively utilizing its resources. The company's profitability ratios suggest that it is well-positioned for future success. The company is highly profitable and efficient in generating returns.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 8.29 | 8.55 | 10.58 | 11.42 | 12.95 |
| Return on Capital Employed (ROCE) | 10 | 11 | 14 | 15 | 15 |
| Return on Equity (ROE) | 8.64 | 9.43 | 10.91 | 9.79 | 11.12 |
| Return on Assets (ROA) | 9.58 | 10.39 | 13.68 | 11.2 | 13.16 |
| Operating Margin | 12.25 | 12.75 | 15.13 | 16.22 | 17.39 |
| Net Margin | 5.59 | 5.16 | 5.57 | 8.75 | 9.62 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
Artemis Medicare Services exhibits mixed efficiency. It demonstrates strengths in inventory and receivables management, but struggles with fixed asset and capital turnover. The company's ability to quickly convert inventory into sales is a positive sign, but its underutilization of fixed assets and capital is a concern. The company needs to improve its asset utilization to enhance its overall efficiency and profitability. There is a need to improve the use of fixed assets to increase revenue generation.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 1.13 | 1.22 | 1.22 | 1.26 | 1.34 |
| Inventory Turnover Ratio | 46.27 | 51.85 | 65.5 | 83 | 81.83 |
| Receivables Turnover Ratio | 8.67 | 8.88 | 9.35 | 9.56 | 9.78 |
| Days Sales in Inventory Ratio | 7.89 | 7.04 | 5.57 | 4.4 | 4.46 |
| Receivable Days | 42.1 | 41.1 | 39.04 | 38.18 | 37.32 |
| Capital Turnover Ratio | 1.03 | 1.11 | 1.18 | 0.86 | 0.93 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
Artemis Medicare Services demonstrates a strong ability to meet its interest and dividend obligations. The company's interest coverage ratio is good, indicating that it can comfortably cover its interest expenses. Additionally, its equity dividend coverage ratio is excellent, suggesting a strong ability to pay dividends to its shareholders. The company is well-positioned to meet its financial obligations and reward its investors.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 4.08 | 3.55 | 3.19 | 4.38 | 5.96 |
| Equity Dividend Coverage Ratio | 6.25 | 8.33 | 14.29 | 14.29 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
Artemis Medicare Services has a solid financial structure. The company has a reasonable level of debt and a healthy equity base. This indicates that the company is not overly reliant on debt financing and has a strong financial foundation. The company's solvency ratios suggest that it is well-positioned to meet its long-term obligations. The company maintains a good balance between debt and equity, ensuring a stable financial position.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.33 | 0.39 | 0.4 | 0.23 | 0.19 |
| Debt to Equity Ratio | 0.49 | 0.64 | 0.67 | 0.3 | 0.23 |
| Equity Ratio | 0.67 | 0.61 | 0.6 | 0.77 | 0.81 |
| Debt To Asset Ratio | 0.25 | 0.29 | 0.3 | 0.19 | 0.16 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's ability to meet its short-term obligations is a mixed bag. While it has a good quick ratio and cash ratio, its current ratio is average, and its operating cash flow ratio is poor. This suggests that the company may face challenges in meeting its short-term obligations. The company has sufficient liquid assets, but its ability to generate cash from its operations is a concern.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 0.92 | 0.84 | 0.96 | 2.16 | 2.22 |
| Quick Ratio | 0.85 | 0.78 | 0.91 | 2.12 | 2.17 |
| Cash Ratio | 0.16 | 0.21 | 0.27 | 1.49 | 0.77 |
| Operating Cash Flow Ratio | 0.35 | 0.52 | 0.48 | 0.55 | 0.49 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Indraprastha Medical Corporation Ltd | 8.72 | 19.12 | Neutral | 267.00 | 20.03 | 184.00 |
| 2 | Artemis Medicare Services Ltd | 7.77 | 39.49 | Overvalued | 188.00 | 6.53 | 104.00 |
| 3 | Shalby Ltd | 5.85 | 49.37 | Undervalued | 143.00 | 10.45 | 35.00 |
| 4 | Yatharth Hospital & Trauma Care Services Ltd | 4.89 | 46.14 | Neutral | 292.00 | 9.90 | 170.00 |
Artemis Medicare Services' management demonstrates mixed effectiveness. The company shows strong profit growth and improving operating profit margins, indicating positive operational efficiency. However, there are concerns regarding slowing sales growth and increasing debt levels. While Return on Equity is healthy, the high Enterprise Value relative to Market Cap plus Debt suggests that the company's debt is contributing significantly to its valuation. Overall, the management's strengths in profitability and operational efficiency are tempered by sales growth concerns and debt management challenges.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Profit Growth | 37% (3Y CAGR) | Strong and sustainable profit growth |
| OPM Improvement | 12% (Mar 2019) to 16% (Mar 2025) | Improving operational efficiency | |
| ROE | 13% (Last Year) | Good returns on shareholder funds | |
| CONS | Sales Growth | 7% (TTM) | Slowing sales growth |
| Increasing Debt | ₹ 114 Cr (Mar 2019) to ₹ 290 Cr (Mar 2025) | Rising debt levels |
Financial Performance & Growth
Artemis Medicare Services has demonstrated robust profit growth, but sales growth shows a recent slowdown. Compounded Profit Growth is strong at 37% (3Y CAGR) and 68% (TTM). However, Compounded Sales Growth is 19% (3Y) and 7% (TTM), indicating a deceleration in revenue expansion. YOY Sales Growth % has decreased from 30.68% in Mar 2023 to 6.51% in Mar 2025. OPM % has improved from 12% in Mar 2019 to 16% in Mar 2025, reflecting enhanced operational efficiency. Quarterly sales and profit fluctuations are evident, but the overall trend shows growth.
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Sales Growth (%) | 3.39% | -27.72% | 35.85% | 32.92% | 19.14% | 6.64% |
Capital Efficiency & Returns
Artemis Medicare Services demonstrates mixed capital efficiency. The ROCE % has improved from 10% in Mar 2020 to 15% in Mar 2025, indicating better capital utilization. ROE is 13% (Last Year), reflecting good returns on shareholder funds. Debtor Days have improved from 52 in Mar 2019 to 39 in Mar 2025, suggesting more efficient working capital management.
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROCE (%) | 10% | 4% | 10% | 11% | 14% | 15% |
Financial Health & Prudence
Artemis Medicare Services faces challenges in debt management. Borrowings have increased from ₹ 114 Cr in Mar 2019 to ₹ 290 Cr in Mar 2025, indicating rising leverage. Dividend Payout % is inconsistent, with no payouts until Mar 2023 and then fluctuating between 16% (Mar 2023) and 7% (Mar 2025). The Enterprise Value is high relative to Market Cap plus Debt, suggesting that debt significantly contributes to the company's valuation.
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Borrowings (₹ Cr) | 114 | 113 | 147 | 201 | 286 | 320 | 290 |
| Dividend Payout (%) | -0% | -0% | -0% | -0% | 16% | 12% | 7% |
Shareholding & Ownership Structure
The shareholding pattern of Artemis Medicare Services reveals some shifts. Promoter holding has slightly decreased from 69.82% in Mar 2020 to 67.17% in Mar 2025. FII holding is minimal but increasing, from 0.00% in Mar 2020 to 0.31% in Mar 2025. DII holding has increased from 1.22% in Mar 2020 to 5.04% in Mar 2025, indicating growing institutional interest. The number of shareholders has increased significantly from 5,590 in Mar 2020 to 28,397 in Mar 2025, suggesting broader public participation.
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Promoter Holding (%) | 69.82% | 69.82% | 69.82% | 68.91% | 68.03% | 67.17% |
| FII Holding (%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.10% | 0.31% |
| DII Holding (%) | 1.22% | 1.22% | 1.10% | 1.37% | 2.61% | 5.04% |
Artemis Medicare Services exhibits a moderate risk profile. The company shows positive trends in profitability and operational efficiency. However, the increasing debt levels pose a financial risk. The declining sales growth in recent times may impact future profitability. While institutional holding is increasing, the decrease in promoter holding raises some concerns.
Segment performance volatility
The volatility in quarterly sales and profit figures indicates potential instability in Artemis Medicare Services' segment performance. While there is an overall growth trend, the fluctuations suggest varying performance across different segments or operational areas. For example, YOY Sales Growth % has varied across quarters, from 30.68% in Mar 2023 to 6.51% in Mar 2025. Similarly, YOY Profit Growth % has seen significant fluctuations.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10259.01Bullish
- SMA 20260.42Bearish
- SMA 50260.48Bearish
- EMA 10259.46Bullish
- EMA 20259.95Bearish
- EMA 50261.01Bearish
- DEMA 10259.08Bullish
- DEMA 20259.15Bullish
- DEMA 50258.94Bullish
- TEMA 10259.37Bullish
- TEMA 20258.77Bullish
- TEMA 50259.65Bullish
- MACD-0.62Bearish
- ADX18.86Weak Trend
- IndicatorValueSignal
- RSI48.84Neutral
- CCI-35.68Neutral
- ROC 90.60Bullish
- ROC 14-1.78Bearish
- ROC 25-0.04Bearish
- Stoch K40.38Neutral
- Stoch D38.67Neutral
- IndicatorValueSignal
- BB Upper265.07Neutral
- BB Middle260.42Neutral
- BB Lower255.77Neutral
- ATR2.29Low Volatility
- IndicatorValueSignal
- MFI40.45Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10259.93Bearish
- SMA 20261.16Bearish
- SMA 50261.86Bearish
- EMA 10259.72Bullish
- EMA 20260.32Bearish
- EMA 50262.51Bearish
- DEMA 10258.99Bullish
- DEMA 20259.28Bullish
- DEMA 50259.25Bullish
- TEMA 10258.74Bullish
- TEMA 20259.55Bullish
- TEMA 50256.94Bullish
- MACD-0.82Bearish
- ADX14.49Weak Trend
- IndicatorValueSignal
- RSI47.71Neutral
- CCI-58.78Neutral
- ROC 9-1.70Bearish
- ROC 140.81Bullish
- ROC 252.04Bullish
- Stoch K38.16Neutral
- Stoch D34.77Neutral
- IndicatorValueSignal
- BB Upper266.36Neutral
- BB Middle261.16Neutral
- BB Lower255.95Neutral
- ATR3.24Low Volatility
- IndicatorValueSignal
- MFI57.52Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10261.18Bearish
- SMA 20259.60Bullish
- SMA 50268.84Bearish
- EMA 10260.43Bearish
- EMA 20261.69Bearish
- EMA 50262.90Bearish
- DEMA 10259.69Bullish
- DEMA 20258.88Bullish
- DEMA 50267.23Bearish
- TEMA 10260.02Bearish
- TEMA 20258.63Bullish
- TEMA 50N/AN/A
- MACD-1.89Bullish
- ADX11.33Weak Trend
- IndicatorValueSignal
- RSI45.70Neutral
- CCI-11.83Neutral
- ROC 9-1.79Bearish
- ROC 141.03Bullish
- ROC 25-2.38Bearish
- Stoch K37.35Neutral
- Stoch D39.03Neutral
- IndicatorValueSignal
- BB Upper265.79Neutral
- BB Middle259.60Neutral
- BB Lower253.41Neutral
- ATR5.61Low Volatility
- IndicatorValueSignal
- MFI48.92Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10259.85Bearish
- SMA 20266.99Bearish
- SMA 50257.18Bullish
- SMA 100243.76Bullish
- SMA 200249.35Bullish
- EMA 10261.79Bearish
- EMA 20263.52Bearish
- EMA 50258.42Bullish
- EMA 100253.08Bullish
- EMA 200251.50Bullish
- DEMA 10258.92Bearish
- DEMA 20263.45Bearish
- DEMA 50267.45Bearish
- DEMA 100258.07Bullish
- DEMA 200252.74Bullish
- TEMA 10258.48Bullish
- TEMA 20258.02Bullish
- TEMA 50271.66Bearish
- TEMA 100265.24Bearish
- TEMA 200250.09Bullish
- MACD-0.69Bearish
- ADX15.29Weak Trend
- IndicatorValueSignal
- RSI45.90Neutral
- CCI-83.34Neutral
- ROC 14-3.34Bearish
- ROC 25-6.77Bearish
- Stoch K23.77Neutral
- Stoch D23.83Neutral
- IndicatorValueSignal
- BB Upper284.49Neutral
- BB Middle266.99Neutral
- BB Lower249.49Neutral
- ATR9.41Low Volatility
- IndicatorValueSignal
- MFI40.51Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20243.56Bullish
- SMA 50247.92Bullish
- EMA 20252.68Bullish
- EMA 50250.54Bullish
- DEMA 20258.18Bullish
- DEMA 50253.71Bullish
- TEMA 20265.66Bearish
- TEMA 50246.01Bullish
- MACD5.40Bullish
- ADX22.63Weak Trend
- IndicatorValueSignal
- RSI53.40Neutral
- CCI58.35Neutral
- ROC 1412.84Bullish
- ROC 25-4.94Bearish
- Stoch K70.60Neutral
- Stoch D76.43Neutral
- IndicatorValueSignal
- BB Upper282.42Neutral
- BB Middle243.56Neutral
- BB Lower204.70Neutral
- ATR19.44Low Volatility
- IndicatorValueSignal
- MFI67.57Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6246.98Bullish
- SMA 12246.80Bullish
- SMA 24260.44Bullish
- EMA 6249.76Bullish
- EMA 12249.52Bullish
- EMA 24237.45Bullish
- DEMA 6251.38Bullish
- DEMA 12252.02Bullish
- DEMA 24273.99Bearish
- TEMA 6256.08Bullish
- TEMA 12243.53Bullish
- TEMA 24254.52Bullish
- MACD53.82Bearish
- ADX23.04Weak Trend
- IndicatorValueSignal
- RSI59.17Neutral
- CCI79.49Neutral
- ROC 2549.87Bullish
- ROC 50495.56Bullish
- Stoch K48.77Neutral
- Stoch D66.52Neutral
- IndicatorValueSignal
- BB Upper325.69Neutral
- BB Middle261.95Neutral
- BB Lower198.21Neutral
- ATR45.53High Volatility
- IndicatorValueSignal
- MFI62.61Neutral